{"ticker": {"uuid": "1afd823b-7358-4154-a0e6-9ebcb7bcf517", "symbol": "TEVAN", "name": "Teva Pharmaceutical Industries Limited", "exchange": "MEX", "country": "MX", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Teva Pharmaceutical Advances Neuroscience Pipeline With Strong AUSTEDO Growth & New Acquisition", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6wFBVV95cUxQNGpnWmNCRENZRHhpY21KYWRzN0NoX1N3LWhubXNncHNJOVYyYjAyenFyeDl0dGc3cUl6bnNMM0JQaTFJMFpLMXk2eW5GLU9sREtGd3U2VUsyNWtWMXhVYlEzcko5bExDbnAwdzVfWXJBVmtWczlCdDd6R2hDQUh1cFJCd052SXd3RDF5aG01dllIbnNKeEFycVBFSzIxN3QyLV93TWd3MDE3WV9fbWU5X2R5aE1SdUNIYXNyV0FIdU41aW95ZmZHSlk0VF9Jd2dkb2gxTUh3dldqZGlkRUdhZkhxY3N1TngybmZ3?oc=5", "source_name": "Streetwise Reports", "published_at": "2026-06-17T09:11:24+00:00", "published_display": "17 Jun 2026 09:11", "sentiment": "positive", "sentiment_pct": 82, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Teva Pharmaceutical Biosimilar Growth and Market Outlook 2026 - News and Statistics", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPNlFUUVFkelVjeTlJRzVwM3FPS2k2Vlp3V2hLMGRjRUcwTmpzZkhFOWJQbzJIb3pmN0wtZ3Jqb19famQ0bGJhV1FHYmZjSWI1UUpkaEZ3ektXVXpKam9Ib3BnbjNRN3RKRlYtWkJFN1VKNFVIajFFdHJQSVpQTVZfRUhjRTYwb1A0alBwdjRRVkRaelBaLThYMDZkMA?oc=5", "source_name": "IndexBox", "published_at": "2026-06-12T20:50:00+00:00", "published_display": "12 Jun 2026 20:50", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Teva Pharmaceuticals (TEVA) Crashed on Wednesday?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxQNm93SEVWUUhnQ1EzMlNnZjZIc0t6OFZIeHlkZWpJcDA5R3R5enJpcUEyWm1nVXBoQTVOeV93OFFMS2Y0LTdmTXpPcVRHdkpOS1QtVnp6QUszeXBtMFl4d2l1V2NyNjdSdXhZdGM0TTVaWHVBbXJvTnBQQjZnRW9qYnBUdVRydGxjenBJ?oc=5", "source_name": "Market source", "published_at": "2025-01-30T08:00:00+00:00", "published_display": "30 Jan 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Teva Pharmaceutical Advances Neuroscience Pipeline With Strong AUSTEDO Growth & New Acquisition", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6wFBVV95cUxQNGpnWmNCRENZRHhpY21KYWRzN0NoX1N3LWhubXNncHNJOVYyYjAyenFyeDl0dGc3cUl6bnNMM0JQaTFJMFpLMXk2eW5GLU9sREtGd3U2VUsyNWtWMXhVYlEzcko5bExDbnAwdzVfWXJBVmtWczlCdDd6R2hDQUh1cFJCd052SXd3RDF5aG01dllIbnNKeEFycVBFSzIxN3QyLV93TWd3MDE3WV9fbWU5X2R5aE1SdUNIYXNyV0FIdU41aW95ZmZHSlk0VF9Jd2dkb2gxTUh3dldqZGlkRUdhZkhxY3N1TngybmZ3?oc=5", "source_name": "Streetwise Reports", "published_at": "2026-06-17T09:11:24+00:00", "published_display": "17 Jun 2026 09:11", "sentiment": "positive", "sentiment_pct": 82, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Teva Pharmaceutical Biosimilar Growth and Market Outlook 2026 - News and Statistics", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPNlFUUVFkelVjeTlJRzVwM3FPS2k2Vlp3V2hLMGRjRUcwTmpzZkhFOWJQbzJIb3pmN0wtZ3Jqb19famQ0bGJhV1FHYmZjSWI1UUpkaEZ3ektXVXpKam9Ib3BnbjNRN3RKRlYtWkJFN1VKNFVIajFFdHJQSVpQTVZfRUhjRTYwb1A0alBwdjRRVkRaelBaLThYMDZkMA?oc=5", "source_name": "IndexBox", "published_at": "2026-06-12T20:50:00+00:00", "published_display": "12 Jun 2026 20:50", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Teva Pharmaceuticals (TEVA) Crashed on Wednesday?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxQNm93SEVWUUhnQ1EzMlNnZjZIc0t6OFZIeHlkZWpJcDA5R3R5enJpcUEyWm1nVXBoQTVOeV93OFFMS2Y0LTdmTXpPcVRHdkpOS1QtVnp6QUszeXBtMFl4d2l1V2NyNjdSdXhZdGM0TTVaWHVBbXJvTnBQQjZnRW9qYnBUdVRydGxjenBJ?oc=5", "source_name": "Market source", "published_at": "2025-01-30T08:00:00+00:00", "published_display": "30 Jan 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 48, "total_relevant": 3, "sentiment_summary": {"positive": 2, "negative": 0, "neutral": 1, "score": 69, "total": 3, "label": "Constructive news tone", "tone": "positive"}, "classifier": {"primary_event": "deals", "primary_label": "Deals and strategy", "confidence": 54, "events": [{"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}, {"event": "general", "label": "Market update", "weight": 0.55, "count": 1}], "positive_events": 2, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 597.5, "latest_week": "2026-06-19", "one_week_move": 0.0, "four_week_move": 9.2, "twelve_week_move": 11.0, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.257745, "market_dynamics_buy_signal": false, "relative_strength": 21.808004, "fair_value_gap": 77.1, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "negative", "expectation_probability": 44.9911, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.0% over one week, +9.2% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 62, "badges": ["Sentiment confirms active trend", "Positive but stretched"], "opportunities": ["Constructive tone aligns with the Sharemaestro trend signal."], "risks": ["Constructive tone is arriving with price materially above fair value."], "event_label": "Deals and strategy", "sentiment_word": "constructive"}, "charts": {"sources": [{"label": "Streetwise Reports", "count": 1}, {"label": "IndexBox", "count": 1}, {"label": "Market source", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 3}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Deals and strategy", "count": 1}, {"label": "Guidance", "count": 1}, {"label": "Market update", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "69/100", "tone": "positive", "text": "Constructive news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Deals and strategy", "tone": "positive", "text": "54/100 classification confidence."}, {"label": "Company focus", "value": "3", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+0.0% over one week, +9.2% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Teva Pharmaceutical Advances Neuroscience Pipeline With Strong AUSTEDO Growth & New Acquisition"}], "updated_at": "2026-06-22T15:11:54.595396+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}